Scilex Holding Company (SCLX)
NASDAQ: SCLX · Real-Time Price · USD
7.40
-0.59 (-7.38%)
At close: Jun 2, 2026, 4:00 PM EDT
7.45
+0.05 (0.68%)
After-hours: Jun 2, 2026, 7:48 PM EDT
Scilex Holding Company Revenue
Scilex Holding Company had revenue of $8.61M in the quarter ending March 31, 2026, with 72.12% growth. This brings the company's revenue in the last twelve months to $33.86M, down -33.22% year-over-year. In the year 2025, Scilex Holding Company had annual revenue of $30.25M, down -46.54%.
Revenue (ttm)
$33.86M
Revenue Growth
-33.22%
P/S Ratio
1.54
Revenue / Employee
$995,941
Employees
34
Market Cap
52.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.25M | -26.34M | -46.54% |
| Dec 31, 2024 | 56.59M | 9.85M | 21.07% |
| Dec 31, 2023 | 46.74M | 8.71M | 22.90% |
| Dec 31, 2022 | 38.03M | 6.72M | 21.45% |
| Dec 31, 2021 | 31.32M | 7.76M | 32.92% |
| Dec 31, 2020 | 23.56M | 2.53M | 12.01% |
| Dec 31, 2019 | 21.03M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pfizer | 63.32B |
| Sanofi | 54.60B |
| Bristol-Myers Squibb Company | 48.48B |
| GSK plc | 43.29B |
| Biogen | 9.94B |
| Grifols | 8.58B |
| Organon & Co. | 6.16B |
| Amarin Corporation | 216.76M |
SCLX News
- 3 hours ago - Scilex files to sell 2.08M shares of common stock - TheFly
- 3 hours ago - Scilex files to sell 6.58M shares of common stock for holders - TheFly
- 11 days ago - Scilex approves dividend of Semnur Pharmaceuticals shares - TheFly
- 11 days ago - Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026 - GlobeNewsWire
- 4 weeks ago - Scilex’s ACEA Thera, ACEA Pharma enter definitive agreement with Phoenix Asia - TheFly
- 4 weeks ago - Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited - GlobeNewsWire
- 4 weeks ago - Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of April 30, 2026 - GlobeNewsWire
- 5 weeks ago - Datavault to receive $120M cash contribution from Scilex - TheFly